首页 | 本学科首页   官方微博 | 高级检索  
     


Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin‐based chemotherapy
Authors:Matthew D. Galsky MD  Erin Moshier MS  Susan Krege MD  Chia‐Chi Lin MD  PhD  Noah Hahn MD  Thorsten Ecke MD  Guru Sonpavde MD  James Godbold PhD  William K. Oh MD  Aristotle Bamias MD
Affiliation:1. Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Mount Sinai School of Medicine, , New York, New York;2. Department of Preventive Medicine, Mount Sinai School of Medicine, , New York, New York;3. Urological Clinic, Alexianer Krefeld GmbH, , Krefeld, Germany;4. Department of Oncology, National Taiwan University Hospital, , Taipei, Taiwan;5. Division of Hematology and Oncology, Department of Medicine, Indiana University Melvin and Bren Simon Cancer Center, , Indianapolis, Indiana;6. Department of Urology, HELIOS Hospital, , Bad Saarow, Germany;7. US Oncology Research, LLC, McKesson Specialty Health, , The Woodlands, Texas;8. Texas Oncology, , Webster, Texas;9. Department of Therapeutics, University of Athens Medical School, Hellenic Cooperative Oncology Group, , Athens, Greece
Abstract:
Keywords:urothelial cancer  bladder cancer  prognosis  metastatic  chemotherapy  cisplatin
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号